한글목차

좌심이 폐쇄(LAAC) 디바이스의 동향과 전망

세계 좌심이 폐쇄(LAAC) 디바이스 시장은 2024년부터 2030년까지 17.7%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 38억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 추진 요인은 심방세동(AF) 사례 증가, 첨단 기술의 채택 증가, 세계 라이프 스타일 장애입니다. 세계 좌심이 폐쇄(LAAC) 디바이스 시장의 미래는 병원 및 외래수술센터(ASC) 시장의 기회로 인해 유망합니다.

좌심이 폐쇄(LAAC) 디바이스 시장 인사이트

Lucintel은 합병증이 적고, 입원 기간이 짧고, 30일 재입원이 적은 환자에게 사용되기 때문에 예측 기간 동안 심내막이 더 큰 부문을 차지할 것으로 예상하고 있습니다.

이 시장에서 병원은 좌심방세동(LAA) 시술에 대한 선호도가 높아지고 병원에서 좌심방세동 폐쇄장치에 대한 수용이 증가함에 따라 가장 큰 시장으로 남아있을 것으로 보입니다.

북미는 심방세동 증가와 고령화로 인해 여전히 가장 큰 시장입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장
  • 심외막
  • 심내막
• 최종 용도별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장
  • 병원
  • 외래수술센터(ASC)
  • 기타

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장
• 북미의 좌심이 폐쇄(LAAC) 디바이스 시장
• 유럽의 좌심이 폐쇄(LAAC) 디바이스 시장
• 아시아태평양의 좌심이 폐쇄(LAAC) 디바이스 시장
• 기타 지역의 좌심이 폐쇄(LAAC) 디바이스 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 성장 기회
  • 최종 용도별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 성장 기회
  • 지역별 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 성장 기회
• 세계 좌심이 폐쇄(LAAC) 디바이스 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 좌심이 폐쇄(LAAC) 디바이스 시장 능력 확대
  • 세계의 좌심이 폐쇄(LAAC) 디바이스 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Abbott Laboratories
• AtriCure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

영문목차

Left Atrial Appendage Closure Devices Trends and Forecast

The future of the global left atrial appendage closure devices market looks promising with opportunities in the hospitals and ambulatory surgery centers markets. The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 17.7% from 2024 to 2030. The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

A more than 150-page report is developed to help in your business decisions.

Left Atrial Appendage Closure Devices by Segment

The study includes a forecast for the global left atrial appendage closure devices by product, end use, and region.

Left Atrial Appendage Closure Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Epicardial
• Endocardial

Left Atrial Appendage Closure Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Ambulatory Surgery Centers
• Others

Left Atrial Appendage Closure Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Left Atrial Appendage Closure Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies left atrial appendage closure devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the left atrial appendage closure devices companies profiled in this report include-

• Abbott Laboratories
• Atricure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

Left Atrial Appendage Closure Devices Market Insights

Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Within this market, hospitals will remain the largest segment due to growing preference for left atrial appendage (LAA) procedures and an increase in hospital acceptance of left atrial appendage closure devices.

North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Features of the Global Left Atrial Appendage Closure Devices Market

Market Size Estimates: Left atrial appendage closure devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Left atrial appendage closure devices market size by product, end use, and region in terms of value ($B).

Regional Analysis: Left atrial appendage closure devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, end uses, and regions for the left atrial appendage closure devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the left atrial appendage closure devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the left atrial appendage closure devices market size?

Answer: The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030.

Q.2 What is the growth forecast for left atrial appendage closure devices market?

Answer: The global left atrial appendage closure devices market is expected to grow with a CAGR of 17.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the left atrial appendage closure devices market?

Answer: The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

Q4. What are the major segments for left atrial appendage closure devices market?

Answer: The future of the left atrial appendage closure devices market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q5. Who are the key left atrial appendage closure devices market companies?

Answer: Some of the key left atrial appendage closure devices companies are as follows:

• Abbott Laboratories
• AtriCure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

Q6. Which left atrial appendage closure devices market segment will be the largest in future?

Answer: Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Q7. In left atrial appendage closure devices market, which region is expected to be the largest in next 5 years?

Answer: North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the left atrial appendage closure devices market by type (epicardial and endocardial), end use (hospitals, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Left Atrial Appendage Closure Devices Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Left Atrial Appendage Closure Devices Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Left Atrial Appendage Closure Devices Market by Product
  • 3.3.1: Epicardial
  • 3.3.2: Endocardial
• 3.4: Global Left Atrial Appendage Closure Devices Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Ambulatory Surgery Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Left Atrial Appendage Closure Devices Market by Region
• 4.2: North American Left Atrial Appendage Closure Devices Market
  • 4.2.1: North American Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.2.2: North American Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.3: European Left Atrial Appendage Closure Devices Market
  • 4.3.1: European Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.3.2: European Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.4: APAC Left Atrial Appendage Closure Devices Market
  • 4.4.1: APAC Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.4.2: APAC Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.5: ROW Left Atrial Appendage Closure Devices Market
  • 4.5.1: ROW Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.5.2: ROW Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Product
  • 6.1.2: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by End Use
  • 6.1.3: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Region
• 6.2: Emerging Trends in the Global Left Atrial Appendage Closure Devices Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Left Atrial Appendage Closure Devices Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Left Atrial Appendage Closure Devices Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: AtriCure
• 7.3: Johnson & Johnson
• 7.4: Aegis Medical
• 7.5: Cardia
• 7.6: Biosense Webster
• 7.7: Sentreheart
• 7.8: Occlutech
• 7.9: Boston Scientific Corporation
• 7.10: Lifetech Scientific Corporation